Insider · CIK 0001751832

Perros Manoussos

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001751832

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-07-11	Entasis Therapeutics Holdings Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−479K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Director, President and CEO	JOther	−326K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Director, President and CEO	JOther	−145K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Director, President and CEO	JOther	−183K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Director, President and CEO	JOther	−70K sh	—	—	0
2022-07-07	Entasis Therapeutics Holdings Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−56.1K sh	$2.20	−$123K	0
2022-01-18	Entasis Therapeutics Holdings Inc.A Award	Director, President and CEO	AAward	+125K sh	—	—	534,572
2021-11-02	Entasis Therapeutics Holdings Inc.F Tax Payment	Director, President and CEO	FTax Payment	−11.7K sh	$2.94	−$34.4K	135,822
2021-10-19	Entasis Therapeutics Holdings Inc.A Award	Director, President and CEO	AAward	+79.8K sh	—	—	159,500
2021-10-19	Entasis Therapeutics Holdings Inc.S Sale	Director, President and CEO	SSale	−12K sh	$3.19	−$38.2K	147,526
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−87.5K sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+58.3K sh	—	—	58,307
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−167K sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+129K sh	—	—	128,531
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−79.7K sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+44.3K sh	—	—	44,276
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−124K sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+95K sh	—	—	95,000
2021-01-15	Entasis Therapeutics Holdings Inc.A Award	Director, President and CEO	AAward	+79.8K sh	—	—	79,750
2020-01-23	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+145K sh	—	—	145,000
2019-01-18	Entasis Therapeutics Holdings Inc.Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+124K sh	—	—	123,500
2018-09-25	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+79.7K sh	—	—	79,698

Recent filings

Accepted (ET)
Jul 114
Perros Manoussos0001104659-22-078800
SEC(opens sec.gov)
Feb 154
Perros Manoussos0001104659-22-023781
SEC(opens sec.gov)
Jan 194
Perros Manoussos0001104659-22-005423
SEC(opens sec.gov)
Nov 34
Perros Manoussos0001104659-21-133627
SEC(opens sec.gov)
Oct 204
Perros Manoussos0001104659-21-128067
SEC(opens sec.gov)
Jan 194
Perros Manoussos0001104659-21-005315
SEC(opens sec.gov)
Jan 274
Perros Manoussos0001104659-20-007120
SEC(opens sec.gov)

Companies

Entasis Therapeutics Holdings Inc.Director, President and CEO

Address

C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE

WALTHAM, MA, 02451